Upstate Active Clinical Trials Seeking Participants
Study title
CALGB 50303-Phase III Randomized Study of R-CHOP v. Dose-Adjusted EPOCH-R with Molecular Profiling in Untreated De Novo Diffuse Large B-cell Lymphomas
IRB number
24
What is the purpose of the study?
The purpose of this study is to compare the effects (good and/or bad) on subjects and their lymphoma of two treatments (called R-CHOP with Dose-Adjusted EPOCH-R [DA-EPOCH-R, for short]) to find out which is better.
Who is eligible?
Diagnosis of Diffuse Large B-Cell Lymphoma-stage II, III or IV (some stage I), no prior treatment, good general health, adequate hematologic, kidney and liver function test results.
What is involved if I participate?
- How long is the study?
Treatment with (R-CHOP) will last for 24 weeks (6 months). Treatment with (DA-EPOCH-R) will last fo - Is transportation provided or reimbursed?
No - Is parking provided or reimbursed?
No - What tests and procedures are involved?
Blood tests and urinalysis, ECG (electrocardiogram),CT Scan of the chest, abdomen, and pelvis, Other types of scans (MRI and PET) may be done, Bone marrow aspirate and biopsy, Tumor biopsy, Pregnancy test (if you are a woman of child-bearing potential), HIV test (if appropriate)
Who is the doctor administering the study?
Teresa Gentile, MD
Where will the study take place?
SUNY Upstate Medical University, Satellite offices in Oswego, Oneida and Hill Medical Center
Over what time period is the study scheduled to run?
1/2006 - on going
Who can I contact for more information?
- Name: Ginny Schutt
- Phone: 315-464-8230
- Email: schuttg@upstate.edu
- Fax: 315-464-8280
If you are interested in this trial, please contact the study coordinator or investigator noted above.
